ABI-110

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameABI-110
Drug Alias NameABI-110
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsDiabetic macular oedemaPolypoidal choroidal vasculopathyWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvirmax Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvirmax Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaPolypoidal choroidal vasculopathyWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A